GENE ONLINE|News &
Opinion
Blog

LATEST
M&A Chemoproteomics
Bayer Spends $2 Billion to Acquire a Startup on the Brink of an IPO
2021-08-05
China
Zai Lab, Schrödinger Collaborate to Advance Cancer Program
2021-08-05
VIRTUALMAN Breaking Barriers in Drug Development with AI Solutions
2021-08-05Partner
Funding Drug Discovery
Japan’s SoftBank Buys $5 billion Stake in Roche, Becoming One of its Largest Investors
2021-08-05
Asia-Pacific Oncology
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
Regulatory Gene Therapy
After FDA Lifts Hold, Novartis to Proceed with Clinical Trials for Expensive Rare Disease Therapy
2021-08-04
M&A DNA Sequencing
PacBio Bolsters its Long-Read Sequencing Workflow, Makes Second Acquisition in Two Weeks
2021-08-03
Deals
Astellas Makes a $440M+ Pact with Minovia to Develop Mitochondrial Cell Therapies
2021-08-03
Deals Immuno-oncology
Moderna Banks on Autolus’ Proprietary Tech to Advance Immuno-Oncology Pipeline
2021-08-03
Deals
A Boom in High-Value M&A and Licensing Deals in the Exosome Field
2021-08-02Partner
CRISPR
Game-Changer in Malaria Prevention: CRISPR-Based Genetic Engineering May Eradicate Malaria Vector Anopheles
2021-08-02
Gene and Cell Therapy
BIO Asia 2021 Highlights: Realizing The Promise of Cell and Gene Therapies
2021-08-02
CRISPR
Germline Editing in Marsupials Marks Another Milestone for CRISPR
2021-08-01
Funding Immuno-oncology
Lilly Bets $2 Billion on Kumquat Biosciences for Novel Immune-Oncology Therapeutics
2021-07-31
Manufacturing
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
1 … 126 127 128 129 130 … 220
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top